SR

Sujata Ramalu Gorwadhan

Active Director Director DIN 08181312
DIN 08181312 First appointment Jul 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sujata Ramalu Gorwadhan

Data last updated:

Sujata Ramalu Gorwadhan is a Director at Basophil Pharmaceuticals Private Limited (since 2018). The company operates in Business Services.

DIN 08181312
Primary Designation Director
Industry Business Services
First Appointment 17 Jul 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20182018Active

Board colleagues of Sujata Ramalu Gorwadhan

NameDINCompanyDesignation
Minakshi Milind Dudhe08181311Basophil Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Basophil Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sujata Ramalu Gorwadhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujata Ramalu Gorwadhan

Sujata Ramalu Gorwadhan currently holds 1 directorship: Basophil Pharmaceuticals Private Limited (Director, since 17 Jul 2018).

Sujata Ramalu Gorwadhan was first appointed on 17 Jul 2018 as Director at Basophil Pharmaceuticals Private Limited.

The current boards of Sujata Ramalu Gorwadhan's companies include Minakshi Milind Dudhe (Basophil Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available